NantBio
About:
NantBio offers treatments by developing molecularly targeted drugs, based on the molecular profile of the patient’s tumor.
Description:
Total Funding Amount:
$182M
Headquarters Location:
Culver City, California, United States
Founded Date:
2013-01-01
Founders:
Patrick Soon-Shiong
Number of Employees:
51-100
Last Funding Date:
2024-02-09
IPO Status:
Private
Industries:
© 2025 bioDAO.ai